Eyenovia (EYEN) Stock Analysis

What Eyenovia does

Eyenovia, Inc., a New York-based company established in 2014 (originally incorporated as PGP Holdings V, Inc.), functions as a clinical-stage pharmaceutical firm specializing in ophthalmology. The company utilizes its exclusive microdose array print platform technology and the Optejet branded targeted ocular delivery system to formulate innovative eye treatments. Its primary focus for research and development lies in addressing progressive myopia (nearsightedness), age-related near vision impairment (presbyopia), and pharmacologically induced pupil dilation for eye examinations. Eyenovia's developmental pipeline includes several advanced candidates, all currently undergoing Phase III clinical trials: MicroLine: Designed to enhance near vision for individuals with presbyopia. MicroPine: Aimed at slowing the progression of nearsightedness in pediatric patients. MydCombi: A microdose fixed-combination treatment intended for pharmaceutical mydriasis. Furthermore, Eyenovia has forged strategic alliances for product commercialization. It maintains a licensing agreement with Bausch Health Ireland Limited for the development and commercialization of MicroPine across the United States and Canada. Additionally, an agreement with Arctic Vision (Hong Kong) Limited covers the development and commercialization of both MicroPine and MicroLine in the markets of China and South Korea.

Key metrics

ETFs linked to EYEN

Broad-market and Healthcare sector ETFs an investor holding Eyenovia is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how EYEN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Eyenovia?

Eyenovia trades under the ticker EYEN on NASDAQ.

Which exchange is EYEN listed on?

EYEN is listed on NASDAQ.

What sector does Eyenovia operate in?

Eyenovia is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze EYEN in a portfolio?

PortView shows EYEN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.